[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Iradimed Corp (IRMD)

Iradimed Corp (IRMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,290,699
  • Shares Outstanding, K 12,783
  • Annual Sales, $ 83,810 K
  • Annual Income, $ 22,480 K
  • EBIT $ 28 M
  • EBITDA $ 29 M
  • 60-Month Beta 0.90
  • Price/Sales 14.95
  • Price/Cash Flow 54.32
  • Price/Book 13.10

Options Overview Details

View History
  • Implied Volatility 41.84% (+0.19%)
  • Historical Volatility 27.49%
  • IV Percentile 70%
  • IV Rank 58.95%
  • IV High 57.32% on 09/11/25
  • IV Low 19.61% on 09/05/25
  • Expected Move (DTE 12) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 10
  • Put/Call OI Ratio 1.15
  • Today's Open Interest 495
  • Open Int (30-Day) 425
  • Expected Range 100.97 to 100.97

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.42
  • Number of Estimates 1
  • High Estimate $0.44
  • Low Estimate $0.40
  • Prior Year $0.45
  • Growth Rate Est. (year over year) -6.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
87.91 +14.86%
on 06/03/26
101.13 -0.16%
on 07/02/26
+11.11 (+12.36%)
since 06/02/26
3-Month
76.95 +31.22%
on 05/01/26
101.13 -0.16%
on 07/02/26
+4.74 (+4.93%)
since 04/02/26
52-Week
55.11 +83.22%
on 07/25/25
107.90 -6.42%
on 02/10/26
+39.43 (+64.07%)
since 07/02/25

Most Recent Stories

More News
IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

ORLANDO, Fla., May 20, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in developing innovative MRI-compatible medical devices, today announced that Roger Susi, President and Chief...

IRMD : 100.97 (+2.99%)
IRadimed: Q1 Earnings Snapshot

IRadimed: Q1 Earnings Snapshot

IRMD : 100.97 (+2.99%)
IRADIMED CORPORATION Reports First Quarter 2026 Financial Results

Announces Regular Quarterly Cash Dividend of $0.20 Per Share Reaffirms Full-Year 2026 Revenue and Earnings Guidance  Reports revenue of $22.0 million for the first quarter of 2026, an increase...

IRMD : 100.97 (+2.99%)
IRADIMED CORPORATION to Hold First Quarter 2026 Financial Results Conference Call on May 1, 2026

ORLANDO, Fla., April 27, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2026 first quarter financial results before the market opens on...

IRMD : 100.97 (+2.99%)
IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference

ORLANDO, Fla., April 10, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) today announced that it will participate in the 25th Annual Needham Virtual Healthcare Conference. Iradimed’s...

IRMD : 100.97 (+2.99%)
IRADIMED CORPORATION to Participate at the 38th Annual Roth Conference

ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) today announced that it will participate in the  38 th Annual Roth Conference. Iradimed’s CEO, Roger...

IRMD : 100.97 (+2.99%)
IRadimed: Q4 Earnings Snapshot

IRadimed: Q4 Earnings Snapshot

IRMD : 100.97 (+2.99%)
IRADIMED CORPORATION Reports Record Fourth Quarter and Full Year of 2025 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.20 Per Share from $0.17 Per Share

Reports record revenue of $22.7 million for the fourth quarter of 2025, an increase of $3.3 million, or 17%, compared to the same period in 2024. Reports record GAAP diluted EPS of $0.50 and non-GAAP...

IRMD : 100.97 (+2.99%)
IRADIMED CORPORATION to Hold Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 10, 2026

ORLANDO, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025 fourth quarter and full year financial results before the market...

IRMD : 100.97 (+2.99%)
IRADIMED Announces Special Cash Dividend of $0.50 Per Share

ORLANDO, Fla., Dec. 08, 2025 (GLOBE NEWSWIRE) -- iRadimed Corporation (the “Company”) (NASDAQ: IRMD), announced that its Board of Directors (the “Board”) approved a special cash dividend of $0.50...

IRMD : 100.97 (+2.99%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 70%. The market has entered overbought territory.

See More Share

Business Summary

iRadimed Corporation engages in developing, manufacturing, marketing, and distributing magnetic resonance imaging (MRI) compatible products. It offers non-magnetic intravenous (IV) infusion pump systems, IV tubing sets, IV poles, wireless remote displays/controls under the mRidium name; side car pump...

See More

Key Turning Points

3rd Resistance Point 106.80
2nd Resistance Point 103.96
1st Resistance Point 102.47
Last Price 100.97
1st Support Level 98.14
2nd Support Level 95.30
3rd Support Level 93.81

See More

52-Week High 107.90
Last Price 100.97
Fibonacci 61.8% 87.73
Fibonacci 50% 81.50
Fibonacci 38.2% 75.28
52-Week Low 55.11

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.